Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vincent Chung
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
534 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Kingman Regional Medical Center
Kingman, Arizona, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Sutter Davis Hospital
Davis, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Palo Alto Medical Foundation-Fremont
Fremont, California, United States
- City of Hope at Irvine Lennar
Irvine, California, United States
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California, United States
- Mills Health Center
San Mateo, California, United States
- Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, United States
- Mission Hope Medical Oncology - Santa Maria
Santa Maria, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Feb 2021
- Primary completion
- 1 Oct 2026
- Completion
- 1 Oct 2026
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 88
- Registry id
- NCT04548752
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.